Medezrin Ltd.
Registered name: MEDEZRIN LTD.
Medezrin Ltd. made £0 revenue and a £59.4k loss in the year to 31 Mar 2025.
Medezrin Ltd.’s revenue fell 100% to £0 in the year to 31 Mar 2025, with a loss of £59.4k and 0 employees. The company is classified under “research and experimental development on biotechnology” and is based in London; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- London, London
- Age
- 29 yrs · since 1997
- Type
- Private Limited Company
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Mar 2022 | 31 Mar 2023 | 31 Mar 2024 | 31 Mar 2025 |
|---|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&L | Full P&L |
| Profit & loss | ||||
| Revenue (turnover) | £210k | £49.8k | £26.3k | £0 |
| Cost of sales | £135k | £43.9k | £47.8k | £45.5k |
| Gross profit | £74.9k | £5.9k | −£21.5k | −£45.5k |
| Operating profit | £12.7k | −£30.2k | −£56.1k | −£59.3k |
| Profit before tax | −£3.8k | −£30.3k | −£56.3k | −£59.4k |
| Profit after tax | −£3.8k | −£30.3k | −£56.3k | −£59.4k |
| Profit (best available) | −£3.8k | −£30.3k | −£56.3k | −£59.4k |
| Employees (average) | 0 | 0 | 0 | 0 |
| Ratios | ||||
| Profit margin | −1.8% | −60.9% | −214% | — |
| Gross margin | 35.7% | 11.9% | −81.9% | — |
| Growth (year on year) | ||||
| Revenue growth | — | ▼76.3% | ▼47.2% | ▼100% |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | £31.1k | £1.6k | £1.3k | £2.4k |
| Net assets | −£1.4m | −£1.4m | −£1.5m | −£1.5m |
| Fixed assets | £1.7k | £1.6k | £1.4k | £1.3k |
| Current assets | £31.1k | £1.6k | £14.1k | £15.7k |
| Debtors | £0 | £0 | £12.8k | £13.3k |
| Deferred income | £0 | £0 | — | — |
| Source | FullAccounts · bulk data Dec 2023 | FullAccounts · bulk data Dec 2023 | FullAccounts · bulk data Nov 2024 | FullAccounts · bulk data Oct 2025 |
How the business works
- Profit margin
- —
- Profit ÷ revenue.
- Gross margin
- —
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- —
- Revenue ÷ average employees.
- Profit per employee
- —
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now −£1.5m
- Cash at bank
- ▲87%
- Now £2.4k
- Headcount
- —
- Now 0
- Deferred income
- —
- Now —
- Fixed assets
- ▼10%
- Now £1.3k
Similar profitable businesses
- Astex Therapeutics LimitedCambridge · Research and experimental development on biotechnology
- Revenue
- £404m
- Profit
- £283m
- Staff
- 183
- Charles River U.K. LimitedKent · Research and experimental development on biotechnology
- Revenue
- £22.2m
- Profit
- £18.8m
- Staff
- 129
- Qiagen Manchester LimitedManchester · Research and experimental development on biotechnology
- Revenue
- £53.7m
- Profit
- £11.8m
- Staff
- 239
- Theradex (Europe) LimitedRedhill · Research and experimental development on biotechnology
- Revenue
- £15.2m
- Profit
- £3.1m
- Staff
- 43
- Novogene (UK) Company LimitedCambridge · Research and experimental development on biotechnology
- Revenue
- £38.2m
- Profit
- £2.8m
- Staff
- 68
- Askbio UK LtdMidlothian · Research and experimental development on biotechnology
- Revenue
- £12.5m
- Profit
- £1.8m
- Staff
- 54
Sources
Latest figures from FullAccounts for the year to 31 Mar 2025 (profit −£59.4k), from the Companies House accounts bulk data published Oct 2025. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.